Published in Trends Microbiol on November 01, 1999
Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A (2010) 2.34
Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus. EMBO J (2001) 1.98
Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J Virol (2011) 1.28
The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J Virol (2010) 0.94
Signal transduction networks in cancer: quantitative parameters influence network topology. Cancer Res (2010) 0.91
Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor. PLoS Pathog (2009) 0.78
Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression. J Virol (2015) 0.76
Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line. J Virol (1980) 5.59
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell (1986) 5.13
Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proc Natl Acad Sci U S A (1980) 5.02
Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med (1995) 4.62
Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med (1984) 4.47
DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell (1980) 4.14
Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature (1984) 2.81
DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. J Virol (1978) 2.76
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science (1999) 2.61
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A (1998) 2.49
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol (1990) 2.43
Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol (2000) 2.21
The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer (1987) 2.16
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol (1992) 2.14
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol (1997) 2.05
Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol (1996) 2.03
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol (1995) 2.02
Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis (1989) 1.99
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci U S A (1990) 1.90
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis (1995) 1.75
Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol (2003) 1.74
Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol (1994) 1.67
Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol (1995) 1.58
Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins. J Virol (1995) 1.57
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol (1995) 1.49
Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient. Leukemia (1991) 1.41
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol (1999) 1.33
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol (1993) 1.31
Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology (1999) 1.28
Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol (1997) 1.28
Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci U S A (1992) 1.27
Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol (2000) 1.27
Epstein-Barr virus: structure of the viral DNA and analysis of viral RNA in infected cells. Biochim Biophys Acta (1979) 1.25
Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression. Mol Cell Biol (1998) 1.24
EBV strain variation: geographical distribution and relation to disease state. Virology (1992) 1.23
The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat. J Virol (1995) 1.22
Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol (1990) 1.21
The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. Oncogene (1998) 1.18
LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene (2006) 1.17
Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer (1998) 1.14
Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol (1994) 1.13
A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. J Infect Dis (1991) 1.10
The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology (1999) 1.10
Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol (1992) 1.09
Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. J Virol (1999) 1.07
Variations among isolates of Epstein-Barr virus. Ann N Y Acad Sci (1980) 1.07
Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J Gen Virol (1995) 1.06
Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology (1998) 1.04
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol (1998) 1.03
The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol (1994) 1.00
Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia. J Virol (1990) 1.00
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells. J Virol (1987) 0.99
An Epstein-Barr virus protein interacts with Notch. J Virol (2001) 0.99
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res (1998) 0.98
Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer (1992) 0.97
No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene (1995) 0.94
Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas. J Virol (1994) 0.91
Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome. J Gen Virol (1989) 0.87
Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation. Oncogene (2010) 0.87
Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland. Arctic Med Res (1991) 0.87
Epstein-Barr viral latency and cell immortalization as targets for antisense oligomers. Ann N Y Acad Sci (1992) 0.86
Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol (1989) 0.86
Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions. Oral Dis (2002) 0.85
Purification of biologically active Epstein-Barr virus by affinity chromatography and non-ionic density gradient centrifugation. J Virol Methods (1985) 0.84
Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells. Virology (2001) 0.83
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs. Cancer Res (2001) 0.83
Oral hairy leukoplakia. J Am Acad Dermatol (1990) 0.81
Primary infection by Epstein-Barr virus presenting as aplastic anemia. N Engl J Med (1983) 0.81
Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma. J Virol (1988) 0.81
Malignant neoplasms of the nasal cavity and paranasal sinuses: a series of 256 patients in Mexico City and Monterrey. Is air pollution the missing link? Otolaryngol Head Neck Surg (2000) 0.81
Expression of the c-fgr related transcripts in Epstein-Barr virus-associated malignancies. Int J Cancer (1988) 0.81
The human DNA tumor viruses: human papilloma virus and Epstein-Barr virus. Cancer Treat Res (1989) 0.80
Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line. J Virol (1987) 0.79
Mapping of putative transforming sequences of EBV DNA. IARC Sci Publ (1978) 0.79
Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions. J Infect Dis (1997) 0.78
Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma. Int J Cancer (2000) 0.76
Human neonatal lymphocytes immortalized after microinjection of Epstein-Barr virus DNA. J Virol (1987) 0.75
Detection of Epstein-Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med (1993) 0.75
Acute monoarthritis from infectious mononucleosis. Am J Med (1999) 0.75
Transforming activity of nasopharyngeal carcinoma DNA detectable in mouse JB6 cells. Int J Cancer (1989) 0.75
Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome. Hematol Oncol (1994) 0.75
Successful immune reconstitution in severe combined immunodeficiency despite Epstein-Barr virus and cytomegalovirus infections. Clin Immunol Immunopathol (1985) 0.75
Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma. Leukemia (1987) 0.75
Burkitt's and other non-Hodgkin's lymphomas in adults exposed to a visitor from Africa. N Engl J Med (1985) 0.75